Woodline Partners’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.52M | Sell |
1,018,115
-500,446
| -33% | -$1.73M | 0.02% | 621 |
|
|
2025
Q1 | $3.98M | Buy |
1,518,561
+1,241,657
| +448% | +$3.25M | 0.03% | 560 |
|
|
2024
Q4 | $1.14M | Hold |
276,904
| – | – | 0.01% | 736 |
|
|
2024
Q3 | $1.96M | Buy |
276,904
+3,288
| +1% | +$23.3K | 0.02% | 477 |
|
|
2024
Q2 | $1.78M | Buy |
273,616
+608
| +0.2% | +$3.96K | 0.02% | 426 |
|
|
2024
Q1 | $2.27M | Buy |
273,008
+23,008
| +9% | +$191K | 0.02% | 418 |
|
|
2023
Q4 | $2.75M | Hold |
250,000
| – | – | 0.03% | 360 |
|
|
2023
Q3 | $2.1M | Hold |
250,000
| – | – | 0.02% | 394 |
|
|
2023
Q2 | $3.14M | Sell |
250,000
-25,000
| -9% | -$314K | 0.04% | 365 |
|
|
2023
Q1 | $4.53M | Sell |
275,000
-56,663
| -17% | -$933K | 0.06% | 308 |
|
|
2022
Q4 | $4.96M | Hold |
331,663
| – | – | 0.07% | 318 |
|
|
2022
Q3 | $7.42M | Hold |
331,663
| – | – | 0.1% | 235 |
|
|
2022
Q2 | $5.56M | Hold |
331,663
| – | – | 0.09% | 244 |
|
|
2022
Q1 | $9.93M | Buy |
331,663
+76,062
| +30% | +$2.28M | 0.16% | 176 |
|
|
2021
Q4 | $7.85M | Hold |
255,601
| – | – | 0.11% | 226 |
|
|
2021
Q3 | $8.06M | Sell |
255,601
-32,956
| -11% | -$1.04M | 0.13% | 183 |
|
|
2021
Q2 | $10.6M | Buy |
288,557
+50,117
| +21% | +$1.83M | 0.2% | 131 |
|
|
2021
Q1 | $8.24M | Sell |
238,440
-54,775
| -19% | -$1.89M | 0.18% | 142 |
|
|
2020
Q4 | $12.2M | Sell |
293,215
-58,608
| -17% | -$2.44M | 0.32% | 94 |
|
|
2020
Q3 | $15M | Buy |
+351,823
| New | +$15M | 0.49% | 58 |
|